| Realtime | Geld | Brief | Zeit |
|---|---|---|---|
| 0,064 | 0,096 | 09:18 |
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| HVIVO Aktie jetzt für 0€ handeln | |||||
| Mo | hVIVO PLC - Change of Auditor | - | RNS | ||
| 09.06. | hVIVO PLC - Holding(s) in Company | 1 | RNS | ||
| 01.06. | hVIVO schließt Beratungsvertrag mit Decoy Therapeutics | 2 | Investing.com Deutsch | ||
| 01.06. | hVIVO PLC - Consultancy contract with Decoy Therapeutics | - | RNS | ||
| 29.05. | hVIVO PLC - Grant of awards under Long Term Incentive Plan | - | RNS | ||
| 20.05. | hVIVO PLC - Capital Markets Day | - | RNS | ||
| 13.05. | hVIVO PLC - Result of AGM | 1 | RNS | ||
| 12.05. | hVIVO PLC - Holding(s) in Company | - | RNS | ||
| 07.05. | EARNINGS AND TRADING: MHA expects profit beat; hVIVO wins work | 1 | Alliance News | ||
| 07.05. | hVIVO signs £6m influenza clinical trial deal | 1 | Sharecast | ||
| 07.05. | hVIVO PLC - £6m Influenza HCT contract signed | - | RNS | ||
| 24.04. | hVIVO PLC - Director/PDMR Shareholding | - | RNS | ||
| 22.04. | hVIVO secures large whooping cough vaccine test contract | 1 | Sharecast | ||
| 22.04. | hVIVO PLC - HCT contract signed with ILiAD Biotechnologies | - | RNS | ||
| 17.04. | hVIVO PLC - Annual Report & Notice of AGM | 1 | RNS | ||
| 15.04. | EARNINGS AND TRADING: hVIVO swings to pretax loss after expansion | 1 | Alliance News | ||
| 15.04. | hVIVO PLC - Final Results 2025 | - | RNS | ||
| 14.04. | hVIVO PLC - hVIVO launches unified brand identity | - | RNS | ||
| 14.04. | hVIVO PLC - Influenza HCT contract signed with Traws Pharma | 1 | RNS | ||
| 07.04. | hVIVO PLC - Notice of Results | - | RNS |
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| PLUS THERAPEUTICS | 3,650 | +2,38 % | Plus Therapeutics Inc.: Plus Therapeutics Highlights NCCN CNS Cancers Guidelines Update and Reinforces Clinical Role of CNSide in Leptomeningeal Metastases Monitoring | HOUSTON, July 14, 2026 (GLOBE NEWSWIRE) -- Plus Therapeutics, Inc. (Nasdaq: PSTV) ("Plus" or the "Company"), today highlighted the recent update to the National Comprehensive Cancer Network (NCCN)... ► Artikel lesen | |
| ASENSUS SURGICAL | - | - | Karl Storz to fully integrate Asensus, discontinue Senhance, Luna robots | ||
| JD HEALTH INTERNATIONAL | 4,087 | +1,97 % | UBS: Limited Impact From CN Pharma Retail Regulation; JD HEALTH, ALI HEALTH TPs Cut | ||
| MEDIVOLVE | - | - | Medivolve Inc (2): OSC cites Bharti, Said for disclosure failures | ||
| LIFEWARD | 8,050 | +0,62 % | Lifeward Ltd.: Lifeward Secures Growth Capital to Accelerate Commercial Expansion with Up to $11.2 Million in Strategic Financing | HUDSON, Mass. and YOKNEAM ILLIT, Israel, July 07, 2026 (GLOBE NEWSWIRE) -- Lifeward Ltd. (Nasdaq: LFWD) ("Lifeward" or the "Company"), a diversified biomedical innovation company with a portfolio... ► Artikel lesen | |
| IMUNON | 1,650 | -5,71 % | Celsion Bank wird Mitglied des Liechtensteinischen Bankenverbandes | Vaduz - Die Celsion Bank AG ist seit 1. Juli 2026 Vollmitglied des Liechtensteinischen Bankenverbandes (LBV). Die Celsion Bank bringt ein klares Profil mit Fokus auf digitale Vermögenswerte ein und... ► Artikel lesen | |
| ROCKWELL MEDICAL | 5,630 | 0,00 % | H.C. Wainwright hebt Kursziel für Rockwell Medical Aktie auf 20 $ an | ||
| VIRIDIAN THERAPEUTICS | 16,800 | 0,00 % | Aktien New York Ausblick: Nasdaq erholt - Comcast-Aufspaltung beflügelt Branche | NEW YORK (dpa-AFX) - Die Anleger dürften den jüngsten Kursrückschlag an der New Yorker Tech-Börse Nasdaq direkt zum Wiedereinstieg nutzen. Im Fokus stehen am Montag die jüngste Entspannung im davor... ► Artikel lesen | |
| SINTX TECHNOLOGIES | 1,570 | +0,64 % | SINTX Technologies, Inc.: SINTX Technologies Announces Receipt of More Than $3.2 Million in Contract Manufacturing Purchase Orders | SALT LAKE CITY, Utah, June 22, 2026 (GLOBE NEWSWIRE) -- SINTX Technologies, Inc. (NASDAQ: SINT) ("SINTX" or the "Company"), a leader in advanced silicon nitride ceramics and advanced material technologies... ► Artikel lesen | |
| AETHLON MEDICAL | 0,665 | -2,92 % | Aethlon Medical, Inc.: Aethlon Medical Continues to Observe Directional Changes in Second Cohort of Australian Oncology Clinical Trial Evaluating Hemopurifier | Second cohort findings consistent with previously reported observations; independent statistical analysis planned following completion of all three patient cohorts
... ► Artikel lesen | |
| SAVARIA | 19,400 | 0,00 % | Sun Life, AGF, Savaria at 52-Week Highs on News | ||
| NEURONETICS | 1,515 | -2,57 % | Neuronetics Appoints Robert Greene as Senior Vice President Sales | MALVERN, Pa., June 02, 2026 (GLOBE NEWSWIRE) -- Neuronetics, Inc. (NASDAQ: STIM), a medical technology company focused on designing, developing, and marketing products that improve the quality of... ► Artikel lesen | |
| STAGEZERO LIFE SCIENCES | 0,028 | -100,00 % | StageZero Life Sciences Ltd.: StageZero Announces Partial Revocation of Failure to File Cease Trade Order and Proposed Financing | ||
| IMAC HOLDINGS | - | - | Copley Acquisition Corp (NYSE: COPL) and Ignite Proteomics Announce Business Combination Agreement to Advance Precision Oncology | Ignite Proteomics is a pioneer in delivering pathway-level protein analytics designed to guide precision oncology. HONG KONG, June 11, 2026 (GLOBE NEWSWIRE) -- Copley Acquisition Corp (NYSE: COPL)... ► Artikel lesen | |
| CREO MEDICAL | 0,156 | 0,00 % | Creo Medical - FY25 results validate growth strategy | Creo Medical has reported its headline FY25 results, delivering fully on its guided revenue and cost savings targets for the year. Core revenues were reported at £6.0m, 50% y-o-y growth and within the... ► Artikel lesen |